DOCSLIB.ORG

Pcor: a New Design of Plasmid Vectors for Nonviral Gene Therapy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pcor: a New Design of Plasmid Vectors for Nonviral Gene Therapy Gene Therapy (1999) 6, 1482–1488 1999 Stockton Press All rights reserved 0969-7128/99 $12.00 http://www.stockton-press.co.uk/gt BRIEF COMMUNICATION pCOR: a new design of plasmid vectors for nonviral gene therapy F Soubrier, B Cameron, B Manse, S Somarriba, C Dubertret, G Jaslin, G Jung, C Le Caer, D Dang, JM Mouvault, D Scherman, JF Mayaux and J Crouzet Rhoˆne-Poulenc Rorer, Centre de Recherche de Vitry Alfortville, 13 Quai J Guesde, 94403 Vitry-sur-Seine, France A totally redesigned host/vector system with improved initiator protein, ␲ protein, encoded by the pir gene limiting properties in terms of safety has been developed. The its host range to bacterial strains that produce this trans- pCOR plasmids are narrow-host range plasmid vectors for acting protein; (2) the plasmid’s selectable marker is not an nonviral gene therapy. These plasmids contain a con- antibiotic resistance gene but a gene encoding a bacterial ditional origin of replication and must be propagated in a suppressor tRNA. Optimized E. coli hosts supporting specifically engineered E. coli host strain, greatly reducing pCOR replication and selection were constructed. High the potential for propagation in the environment or in yields of supercoiled pCOR monomers were obtained (100 treated patients. The pCOR backbone has several features mg/l) through fed-batch fermentation. pCOR vectors carry- that increase safety in terms of dissemination and selec- ing the luciferase reporter gene gave high levels of lucifer- tion: (1) the origin of replication requires a plasmid-specific ase activity when injected into murine skeletal muscle. Keywords: gene therapy; plasmid DNA; conditional replication; selection marker; multimer resolution Two different types of DNA vehicles, based criteria.4 These high copy number plasmids carry a mini- on recombinant viruses and bacterial DNA plasmids, are mal amount of bacterial sequences, a conditional origin used in gene therapy. Although virus-based vectors are of replication that prevents dissemination during widely used and very efficient vectors, the potential risks production or therapy and do not contain an antibiotic of viral gene delivery have to be seriously considered. E. resistance gene. coli plasmid-based vectors are non-infectious and versa- The pCOR backbone consists of three bacterial tile vehicles for gene therapy. The manufacture of thera- elements: the 0.4 kb R6K ␥ conditional origin of repli- peutic plasmid DNA that carries potent human genes cation (ori ␥), which requires the R6K ␲ initiator protein becomes a reality. Thus, new approaches that take into to be functional, a 0.2 kb selectable tRNA suppressor account safety and environmental consideration must gene (sup Phe), and a 0.4 kb cer (ColE1 resolution) be developed. fragment to resolve pCOR oligomers. Vector design is a major contributor to the safety of Such plasmids can only replicate in ␲-producing bac- production and therapy. Efforts to improve the plasmid teria considerably limiting their host range. pCOR selec- backbone have focused on the improvement of transgene tion uses expression of a synthetic amber suppressor expression1 or plasmid copy number2 but no rational tRNA gene, specific for phenylalanine (sup Phe), which design in terms of dissemination or size, has been does not require antibiotics. This suppressor corrects an reported. The ColE1-derived bacterial plasmids are cur- amber mutation in argE gene making it possible for the rently used in gene therapy experiments and clinical recombinant host strain to grow on a minimal medium trials. As far as the safety and containment of such gen- lacking arginine (Figure 1). etic material are concerned, two elements are deleterious: The pCOR conditional origin of replication comes from the ColE1 origin of replication and the antibiotic resist- a natural plasmid, R6K, rather than the widely used ance marker. Clinical use of such plasmids could poten- ColE1-derived plasmids. R6K is a 38 kb theta-replicating tially lead to their dissemination in the environment or R (resistance) plasmid. R6K replication functions5 are in the patient. This could be of the utmost importance for clustered in a 5.5 kb DNA fragment that contains three the immunodepressed or for cystic fibrosis patients who origins of replication: ␣ and ␤ that are mainly used, and suffer from chronic bronchopulmonary infections.3 pCOR ␥. All three are under the control of a single replication plasmids, for plasmid with conditional origin of repli- initiation protein, ␲, the product of the pir gene. This pro- cation, were specifically designed and developed for gene tein binds to direct nucleotide sequence repeats (seven therapy. These new plasmids are small efficient transgene tandemly associated 22-bp direct repeats) at the origin of carriers and fulfill several quality assurance and safety replication. It is a dual regulator, exerting both a positive effect on replication and negative feedback that maintains R6K at its characteristic copy number (15 per genome). Correspondence: J Crouzet Copy-up mutants inhibit replication less and maintain Received 21 December 1998; accepted 12 April 1999 the ␥ origin at a high copy number. pir1166 contains a pCOR plasmids for gene therapy F Soubrier et al 1483 Figure 1 pCOR host vector system. The XAC-1pir116 strain requires arginine for growth on minimal medium whereas the arginine deficiency of the pCOR host is corrected by the tRNA sup Phe from the plasmid. The pCOR plasmid, the pir116 and argEam genes, and the XAC-1pir116 chromosome ⌬ are not drawn to scale. The amber mutation is shown by a stop and its correction by a crossed-out stop. XAC-1pir116 genotype: ara (lac-proB)x111 ⌬ Ј + gyrA argEam rpoB thi uidA( MluI)::pir116 F (proB lacI373 lacZu118am). single base mutation (CCC→CTC) that leads to a proline Comparison of pXL2666 (ori ␥-KmR) and pXL2730 (ori to leucine substitution at position 106 in ␲. ␥-KmR-cer) topology (Figure 2) showed that cer leads to The minimum genetic information required to main- monomerization of R6K-derived plasmids. A deletion12 tain R6K derivatives is the 400-bp ␥ origin (ori ␥) and the leading to the inactivation of cer, was introduced into cis or trans-acting ␲ initiator protein.5 Ori ␥ was isolated pXL2666 to generate pXL2754 (ori ␥-KmR-⌬cer). This con- from the suicide vector pUT-T7pol7 as a 0.4 kb BamHI– struct led to the production of plasmid multimers. These EcoRI fragment and was ligated to the kanamycin resist- experiments were also carried out in XAC-1pir and XAC- ance gene (KmR) from pUC4K8 to generate pXL2666. Ori 1pir116 strains (data not shown) which differ only by the ␥ replication and plasmid copy number were assayed in pir allele. Thus, these results shed light on the link wild-type and copy-up backgrounds. pXL2666 was trans- between plasmid multimerization/copy-up pir mutations ferred into a pir (BW190949) and a pir116 strain and multimer resolution via cer-mediated intramolecu- (BW196109)ofE. coli. Agarose gel electrophoresis showed lar recombination. that there were five to 10 more plasmid DNA copies in An important original feature of pCOR is the absence the pir116 than in the pir strain, consistent with previous of an antibiotic resistance gene for selection in E. coli. E. work6 (data not shown). It also pointed out that the coli amber (TAG) suppressor tRNA genes do not contain monomer/oligomer ratio of R6K-derivatives was affected any sequences derived from phages or transposons and by the presence of the copy-up mutation which resulted are very small (less than 100 bp). They are efficient plas- in the major plasmid species being multimers, mostly mid selection markers, even in high-density cultures of dimers (Figure 2). Plasmid linearization by EcoRI indi- E. coli.13 A synthetic amber suppressor tRNA gene, spe- cated that these preparations contained a mixture of cific for phenylalanine (sup Phe) was used as the pCOR monomer and the corresponding oligomers. Topoisomer- marker. sup Phe is expressed from a strong constitutive ase treatment showed that the high molecular weight E. coli promoter, Plpp. This cassette (0.17 kb NarI–HindIII species were circular, supercoiled, plasmid multimers fragment) was isolated from pCT2-F14 and was tested in rather than catenanes. These plasmids are relaxed by E. coli XAC-1.14 The chromosomal argE gene of XAC-1 DNA topoisomerase I and topoisomerase IV10 and no contains an amber mutation that results in a truncated decatenation by topoisomerase IV was observed, and therefore inactive product. As argE encodes N-ace- although this enzyme was active on kinetoplast DNA tylornithinase which is essential for arginine biosynth- (data not shown). Plasmid multimerization is not com- esis, this strain cannot grow in the absence of arginine. patible with pharmaceutical use due to low lot to lot The suppressor tRNA sup Phe causes the correct trans- reproducibility and too few molecules per unit weight. lation of mRNA and the synthesis of an active full-length As well as reducing the number of independently segre- N-acetylornithinase. Thus, XAC-1 can grow on minimal gating molecules, it may also severely reduce plasmid medium lacking arginine as long as the plasmid is stability by affecting plasmid segregation during bacterial present, ensuring plasmid selection. However, this strain cell division. In our effort to resolve multimers, we tested does not synthesize the R6K ␲ initiator protein and thus the cer fragment that can promote monomerization inde- cannot replicate pCOR. Therefore, the ␲-encoding gene, pendently of the replicon involved. This cis-acting DNA pir (or the copy-up mutant pir116), was inserted into the determinant reduces multimerization via a site-specific XAC-1 chromosome by homologous recombination. This recombination event that requires only E. coli-encoded method does not introduce any mobile genetic element, proteins. Two recombinases, XerC and XerD, are neces- such as transposons or phages, that affect genome stab- sary, along with two accessory proteins, ArgR and PepA, ility.
Load more

Recommended publications
  • A Chloroplast Gene Is Converted Into a Nucleargene
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 391-395, January 1988 Biochemistry Relocating a gene for herbicide tolerance: A chloroplast gene is converted into a nuclear gene (QB protein/atrazine tolerance/transit peptide) ALICE Y. CHEUNG*, LAWRENCE BOGORAD*, MARC VAN MONTAGUt, AND JEFF SCHELLt: *Department of Cellular and Developmental Biology, 16 Divinity Avenue, The Biological Laboratories, Harvard University, Cambridge, MA 02138; tLaboratorium voor Genetica, Rijksuniversiteit Ghent, B-9000 Ghent, Belgium; and TMax-Planck-Institut fur Zuchtungsforschung, D-500 Cologne 30, Federal Republic of Germany Contributed by Lawrence Bogorad, September 30, 1987 ABSTRACT The chloroplast gene psbA codes for the the gene for ribulose bisphosphate carboxylase/oxygenase photosynthetic quinone-binding membrane protein Q which can transport the protein product into chloroplasts (5). We is the target of the herbicide atrazine. This gene has been have spliced the coding region of the psbA gene isolated converted into a nuclear gene. The psbA gene from an from the chloroplast DNA of the atrazine-resistant biotype atrazine-resistant biotype of Amaranthus hybridus has been of Amaranthus to the transcriptional-control and transit- modified by fusing its coding region to transcription- peptide-encoding regions of a nuclear gene, ss3.6, for the regulation and transit-peptide-encoding sequences of a bona SSU of ribulose bisphosphate carboxylase/oxygenase of pea fide nuclear gene. The constructs were introduced into the (6). The fusion-gene constructions (designated SSU-ATR) nuclear genome of tobacco by using the Agrobacteium tumor- were introduced into tobacco plants via the Agrobacterium inducing (Ti) plasmid system, and the protein product of tumor-inducing (Ti) plasmid transformation system using the nuclear psbA has been identified in the photosynthetic mem- disarmed Ti plasmid vector pGV3850 (7).
    [Show full text]
  • DNA Microarrays (Gene Chips) and Cancer
    DNA Microarrays (Gene Chips) and Cancer Cancer Education Project University of Rochester DNA Microarrays (Gene Chips) and Cancer http://www.biosci.utexas.edu/graduate/plantbio/images/spot/microarray.jpg http://www.affymetrix.com Part 1 Gene Expression and Cancer Nucleus Proteins DNA RNA Cell membrane All your cells have the same DNA Sperm Embryo Egg Fertilized Egg - Zygote How do cells that have the same DNA (genes) end up having different structures and functions? DNA in the nucleus Genes Different genes are turned on in different cells. DIFFERENTIAL GENE EXPRESSION GENE EXPRESSION (Genes are “on”) Transcription Translation DNA mRNA protein cell structure (Gene) and function Converts the DNA (gene) code into cell structure and function Differential Gene Expression Different genes Different genes are turned on in different cells make different mRNA’s Differential Gene Expression Different genes are turned Different genes Different mRNA’s on in different cells make different mRNA’s make different Proteins An example of differential gene expression White blood cell Stem Cell Platelet Red blood cell Bone marrow stem cells differentiate into specialized blood cells because different genes are expressed during development. Normal Differential Gene Expression Genes mRNA mRNA Expression of different genes results in the cell developing into a red blood cell or a white blood cell Cancer and Differential Gene Expression mRNA Genes But some times….. Mutations can lead to CANCER CELL some genes being Abnormal gene expression more or less may result
    [Show full text]
  • The Novel Protein DELAYED PALE-GREENING1 Is Required For
    www.nature.com/scientificreports OPEN The novel protein DELAYED PALE-GREENING1 is required for early chloroplast biogenesis in Received: 28 August 2015 Accepted: 21 April 2016 Arabidopsis thaliana Published: 10 May 2016 Dong Liu, Weichun Li & Jianfeng Cheng Chloroplast biogenesis is one of the most important subjects in plant biology. In this study, an Arabidopsis early chloroplast biogenesis mutant with a delayed pale-greening phenotype (dpg1) was isolated from a T-DNA insertion mutant collection. Both cotyledons and true leaves of dpg1 mutants were initially albino but gradually became pale green as the plant matured. Transmission electron microscopic observations revealed that the mutant displayed a delayed proplastid-to-chloroplast transition. Sequence and transcription analyses showed that AtDPG1 encodes a putatively chloroplast- localized protein containing three predicted transmembrane helices and that its expression depends on both light and developmental status. GUS staining for AtDPG1::GUS transgenic lines showed that this gene was widely expressed throughout the plant and that higher expression levels were predominantly found in green tissues during the early stages of Arabidopsis seedling development. Furthermore, quantitative real-time RT-PCR analyses revealed that a number of chloroplast- and nuclear-encoded genes involved in chlorophyll biosynthesis, photosynthesis and chloroplast development were substantially down-regulated in the dpg1 mutant. These data indicate that AtDPG1 plays an essential role in early chloroplast biogenesis, and its absence triggers chloroplast-to-nucleus retrograde signalling, which ultimately down-regulates the expression of nuclear genes encoding chloroplast- localized proteins. The chloroplast is an essential organelle in plant cells and plays important roles in primary metabolism, such as CO2 fixation, manufacture of carbon skeletons and fatty acids, and synthesis of amino acids from inorganic nitrogen1.
    [Show full text]
  • Gene Therapy Glossary of Terms
    GENE THERAPY GLOSSARY OF TERMS A • Phase 3: A phase of research to describe clinical trials • Allele: one of two or more alternative forms of a gene that that gather more information about a drug’s safety and arise by mutation and are found at the same place on a effectiveness by studying different populations and chromosome. different dosages and by using the drug in combination • Adeno-Associated Virus: A single stranded DNA virus that has with other drugs. These studies typically involve more not been found to cause disease in humans. This type of virus participants.7 is the most frequently used in gene therapy.1 • Phase 4: A phase of research to describe clinical trials • Adenovirus: A member of a family of viruses that can cause occurring after FDA has approved a drug for marketing. infections in the respiratory tract, eye, and gastrointestinal They include post market requirement and commitment tract. studies that are required of or agreed to by the study • Adeno-Associated Virus Vector: Adeno viruses used as sponsor. These trials gather additional information about a vehicles for genes, whose core genetic material has been drug’s safety, efficacy, or optimal use.8 removed and replaced by the FVIII- or FIX-gene • Codon: a sequence of three nucleotides in DNA or RNA • Amino Acids: building block of a protein that gives instructions to add a specific amino acid to an • Antibody: a protein produced by immune cells called B-cells elongating protein in response to a foreign molecule; acts by binding to the • CRISPR: a family of DNA sequences that can be cleaved by molecule and often making it inactive or targeting it for specific enzymes, and therefore serve as a guide to cut out destruction and insert genes.
    [Show full text]
  • Completion of DNA Replication in Escherichia Coli
    Completion of DNA replication in Escherichia coli Brian M. Wendel1, Charmain T. Courcelle, and Justin Courcelle Department of Biology, Portland State University, Portland, OR 97201 Edited by Philip C. Hanawalt, Stanford University, Stanford, CA, and approved September 29, 2014 (received for review August 5, 2014) The mechanism by which cells recognize and complete replicated would generate a third copy of the chromosomal region where the regions at their precise doubling point must be remarkably efficient, event occurs. Thus, over-replication may be inherent and pro- occurring thousands of times per cell division along the chromo- miscuous during the duplication of genomes. If true, then to somes of humans. However, this process remains poorly understood. ensure that each sequence of the genome replicates once, and Here we show that, in Escherichia coli, the completion of replication only once, per generation, cells must encode an enzymatic system involves an enzymatic system that effectively counts pairs and limits that is essentially able to count in pairs and efficiently degrade cellular replication to its doubling point by allowing converging rep- odd or over-replicated regions until the two nascent end pairs of lication forks to transiently continue through the doubling point replication events can be joined. before the excess, over-replicated regions are incised, resected, and The model organism E. coli is particularly well-suited to dis- joined. Completion requires RecBCD and involves several proteins sect how this fundamental process occurs. In E. coli, the com- associated with repairing double-strand breaks including, ExoI, pletion of replication occurs at a defined region on the genome, SbcDC, and RecG.
    [Show full text]
  • PIR Brochure
    Protein Information Resource Integrated Protein Informatics Resource for Genomic & Proteomic Research For four decades the Protein Information Resource (PIR) has provided databases and protein sequence analysis tools to the scientific community, including the Protein Sequence Database, which grew out from the Atlas of Protein Sequence and Structure, edited by Margaret Dayhoff [1965-1978]. Currently, PIR major activities include: i) UniProt (Universal Protein Resource) development, ii) iProClass protein data integration and ID mapping, iii) PIRSF protein pir.georgetown.edu classification, and iv) iProLINK protein literature mining and ontology development. UniProt – Universal Protein Resource What is UniProt? UniProt is the central resource for storing and UniProt (Universal Protein Resource) http://www.uniprot.org interconnecting information from large and = + + disparate sources and the most UniProt: the world's most comprehensive catalog of information on proteins comprehensive catalog of protein sequence and functional annotation. UniProt Knowledgebase UniProt Reference UniProt Archive (UniProtKB) Clusters (UniRef) (UniParc) When to use UniProt databases Integration of Swiss-Prot, TrEMBL Non-redundant reference A stable, and PIR-PSD sequences clustered from comprehensive Use UniProtKB to retrieve curated, reliable, Fully classified, richly and accurately UniProtKB and UniParc for archive of all publicly annotated protein sequences with comprehensive or fast available protein comprehensive information on proteins. minimal redundancy and extensive sequence searches at 100%, sequences for Use UniRef to decrease redundancy and cross-references 90%, or 50% identity sequence tracking from: speed up sequence similarity searches. TrEMBL section UniRef100 Swiss-Prot, Computer-annotated protein sequences TrEMBL, PIR-PSD, Use UniParc to access to archived sequences EMBL, Ensembl, IPI, and their source databases.
    [Show full text]
  • Mapping Major Replication Origins on the Rice Plastid DNA
    27 Original Paper Plant Biotechnotogy, 19 (1), 27- 35 (2002) Mapping Major Replication Origins on the Rice Plastid DNA Ying WANG1, Kohya TAMURA2, Yasushi SAITOHl'2, Tadashi SAT03 Soh HIDAKA4 and Ken- ichi TSUTSUM11,2,* lUnited Graduate School ofAgricultural Sciences and -~Cryobiosystem Research Center, lwate University, Ueda, Morioka. Iwate 020- 8550, Japan 3Department of Ecology and Evolutionary Biology, Graduate School ofLlfe Science, Tohoku University, Katahira. Sendai, Miyagi 980- 8577, Japan dDepartment of Crop Breeding, National Agricultural Research Center for Tohoku Region, Shimokuriyagawa, Morioka, Iwate 020-0123, Japan. *Corresponding author E-mail address: kentsu@iwate- u.ac.jp Received 5september 2001; accepted 15 october 2001 Abstract To maintain and to differentiate into various plastid lineages, replication of the plastid DNA (ptDNA) and division of the plastid must take place. However, replication initiation of the ptDNA has been less understood. The present study describes identification of the initiation region (origin) of ptDNA replication in the rice cultured cells. RNA- primed newly replicated DNA strands pulse - Iabeled with fractionated. of these strands the bromodeoxyuridine were isolated and size - Locations nascent on ptDNA determined the two major origin regions around the 3' region of each 23S rDNA in the inverted gel electrophoresis of the replication intermediates repeats (IRA and IRB). Two - dimensional agarose suggested that replication from each origin proceeds bidirectionally. This contrasted to replication
    [Show full text]
  • Loss of BCL-3 Sensitises Colorectal Cancer Cells to DNA Damage, Revealing A
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.03.454995; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: Loss of BCL-3 sensitises colorectal cancer cells to DNA damage, revealing a role for BCL-3 in double strand break repair by homologous recombination Authors: Christopher Parker*1, Adam C Chambers*1, Dustin Flanagan2, Tracey J Collard1, Greg Ngo3, Duncan M Baird3, Penny Timms1, Rhys G Morgan4, Owen Sansom2 and Ann C Williams1. *Joint first authors. Author affiliations: 1. Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, Faculty of Life Sciences, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK 2. Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden Glasgow, G61 1BD UK 3. Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN UK 4. School of Life Sciences, University of Sussex, Sussex House, Falmer, Brighton, BN1 9RH UK 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.08.03.454995; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract (250 words) Objective: The proto-oncogene BCL-3 is upregulated in a subset of colorectal cancers (CRC) and increased expression of the gene correlates with poor patient prognosis. The aim is to investigate whether inhibiting BCL-3 can increase the response to DNA damage in CRC.
    [Show full text]
  • Update on Genome Completion and Annotations
    UPDATE ON GENOME COMPLETION AND ANNOTATIONS Update on genome completion and annotations: Protein Information Resource Cathy Wu1and Daniel W. Nebert2* 1Director of PIR, Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC, USA 2Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 558 4347; Fax: þ1 513 558 3562; E-mail: [email protected] Date received (in revised form): 11th January 2004 Abstract The Protein Information Resource (PIR) recently joined the European Bioinformatics Institute (EBI) and Swiss Institute of Bioinformatics (SIB) to establish UniProt — the Universal Protein Resource — which now unifies the PIR, Swiss-Prot and TrEMBL databases. The PIRSF (SuperFamily) classification system is central to the PIR/UniProt functional annotation of proteins, providing classifications of whole proteins into a network structure to reflect their evolutionary relationships. Data integration and associative studies of protein family, function and structure are supported by the iProClass database, which offers value-added descriptions of all UniProt proteins with highly informative links to more than 50 other databases. The PIR system allows consistent, rich and accurate protein annotation for all investigators. Keywords: protein web sites, protein family, functional annotation Introduction system.2 This framework is supported by the iProClass integrated database of protein family, function and structure.3 The high-throughput genome projects have resulted in a rapid iProClass offers value-added descriptions of all UniProt accumulation of genome sequences for a large number of proteins and has highly informative links to more than 50 organisms.
    [Show full text]
  • The Acinetobacter Baumannii Mla System and Glycerophospholipid
    RESEARCH ARTICLE The Acinetobacter baumannii Mla system and glycerophospholipid transport to the outer membrane Cassandra Kamischke1, Junping Fan1, Julien Bergeron2,3, Hemantha D Kulasekara1, Zachary D Dalebroux1, Anika Burrell2, Justin M Kollman2, Samuel I Miller1,4,5* 1Department of Microbiology, University of Washington, Seattle, United States; 2Department of Biochemistry, University of Washington, Seattle, United States; 3Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, United Kingdom; 4Department of Genome Sciences, University of Washington, Seattle, United States; 5Department of Medicine, University of Washington, Seattle, United States Abstract The outer membrane (OM) of Gram-negative bacteria serves as a selective permeability barrier that allows entry of essential nutrients while excluding toxic compounds, including antibiotics. The OM is asymmetric and contains an outer leaflet of lipopolysaccharides (LPS) or lipooligosaccharides (LOS) and an inner leaflet of glycerophospholipids (GPL). We screened Acinetobacter baumannii transposon mutants and identified a number of mutants with OM defects, including an ABC transporter system homologous to the Mla system in E. coli. We further show that this opportunistic, antibiotic-resistant pathogen uses this multicomponent protein complex and ATP hydrolysis at the inner membrane to promote GPL export to the OM. The broad conservation of the Mla system in Gram-negative bacteria suggests the system may play a conserved role in OM biogenesis. The importance of the Mla system to Acinetobacter baumannii OM integrity and antibiotic sensitivity suggests that its components may serve as new antimicrobial *For correspondence: therapeutic targets. [email protected] DOI: https://doi.org/10.7554/eLife.40171.001 Competing interests: The authors declare that no competing interests exist.
    [Show full text]
  • Positive and Negative Roles of an Initiator Protein at an Origin of Replication
    Proc. Natl. Acad. Sci. USA Vol. 83, pp. 9645-9649, December 1986 Genetics Positive and negative roles of an initiator protein at an origin of replication (plasmid R6K/promoter deletions/replication control/autoregulation/immunoassays) MARCIN FILUTOWICZ, MICHAEL J. MCEACHERN, AND DONALD R. HELINSKI Department of Biology, University of California, San Diego, La Jolla, CA 92093 Contributed by Donald R. Helinski, September 5, 1986 ABSTRACT The properties of mutants in the pir gene of origin activity (20) and autogenous regulation of the pir gene, plasmid R6K have suggested that the a protein plays a dual respectively (18, 21). role; it is required for replication to occur and also plays a role A negative role for the irprotein in the control ofR6K copy in the negative control of the plasmid copy number. In our number was suggested originally by the isolation of a mutant present study, we have found that the Xr level in cell extracts of of the R6K derivative plasmid pRK419, designated Cos405, Escherichia coli strains containing R6K derivatives is surpris- that maintained itself at a greatly increased copy number as ingly high (-104 dimers per cell) and that this level is not a result of a single amino acid substitution within the Xr altered in cells carrying high copy number pir mutants. The protein. This mutational change was recessive to wild-type wild-type and a high copy mutant (Cos4O5) pir gene were protein (22). The properties ofthis mutant protein along with inserted downstream of promoters of different strengths to the well-established positive function of ir protein in R6K measure the copy number of an R6K y replicon as a function replication (3, 4) lead to the conclusion that the ir protein ofa 1000-fold range ofintracellular ir concentrations.
    [Show full text]
  • Γboris: Identification of Origins of Replication In
    bioRxiv preprint doi: https://doi.org/10.1101/597070; this version posted April 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. γBOriS: Identification of Origins of Replication in Gammaproteobacteria using Motif-based Machine Learning Theodor Sperlea1, Lea Muth1, Roman Martin1, Christoph Weigel2, Torsten Waldminghaus3, and Dominik Heider1, 1Faculty of Mathematics and Computer Science, Philipps-Universität Marburg, D-35043 Marburg, Germany 2Institute of Biotechnology, Faculty III, Technische Universität Berlin (TUB), Straße des 17. Juni 135, D-10623 Berlin, Germany 3Chromosome Biology Group, LOEWE Center for Synthetic Microbiology (SYNMIKRO), Philipps-Universität Marburg, D-35043 Marburg, Germany The biology of bacterial cells is, in general, based on the infor- All currently available computational methods for the iden- mation encoded on circular chromosomes. Regulation of chro- tification of oriC sequences in bacterial chromosomes rely mosome replication is an essential process which mostly takes on nucleotide disparities on the leading and lagging strand place at the origin of replication (oriC). Identification of high of the DNA double helix (13–17). As replication usually ex- numbers of oriC is a prerequisite to enable systematic stud- tends from oriC bidirectionally, it is one of two chromoso- ies that could lead to insights of oriC functioning as well as mal sites where the leading and lagging strand switch places. novel drug targets for antibiotic development. Current meth- The most frequently used disparity, the GC skew, usually as- ods for identyfing oriC sequences rely on chromosome-wide nu- cleotide disparities and are therefore limited to fully sequenced sumes a V- or inverted V-shape with its minimum indicating genomes, leaving a superabundance of genomic fragments un- the presence of the origin of replication (18, 19).
    [Show full text]